Volunteering in late life is associated with better cognitive function—specifically, better executive function and episodic memory. Those are the findings of a new study from…
RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the…
Alzheimer’s is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing, out of sight, many…
Eisai Co.’s breakthrough Alzheimer’s drug—the first to show it slows the brain-destroying disease—is facing a rocky rollout as doctors grapple with logistical issues, insurance uncertainties…
Higher levels of vitamin B-related amino acids may be linked to the risk of dementia associated with a certain type of air pollutants called particulate…
Chronic constipation may not only be an indicator of gut health, but a potential warning sign of thinking declines, a preliminary study suggests.
A study of data from about 500,000 people in the UK Biobank has uncovered small but statistically significant associations between signs of systemic inflammation and…
For patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in the New England Journal…
Some 80% of older adults see the benefit of tests that can give an early warning that a person’s memory and thinking abilities have started…
Trial results of a new drug to treat Alzheimer’s disease, donanemab, shows it can slow cognitive decline by 35%. The drug has been hailed as…